Vanguard Group Inc Acumen Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,934,039 shares of ABOS stock, worth $3.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,934,039
Previous 1,896,949 1.96%
Holding current value
$3.58 Million
Previous $4.59 Million 4.49%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$2.22 - $3.54 $82,339 - $131,298
37,090 Added 1.96%
1,934,039 $4.8 Million
Q2 2024

Aug 13, 2024
BUY
$2.14 - $4.01 $496,246 - $929,882
231,891 Added 13.93%
1,896,949 $4.59 Million
Q1 2024

May 10, 2024
SELL
$2.97 - $4.64 $518,247 - $809,652
-174,494 Reduced 9.49%
1,665,058 $6.74 Million
Q4 2023

Feb 14, 2024
SELL
$1.86 - $4.48 $31,620 - $76,160
-17,000 Reduced 0.92%
1,839,552 $7.06 Million
Q3 2023

Nov 14, 2023
BUY
$4.15 - $9.72 $4.66 Million - $10.9 Million
1,121,700 Added 152.64%
1,856,552 $7.7 Million
Q2 2023

Aug 14, 2023
BUY
$3.59 - $6.59 $412 - $757
115 Added 0.02%
734,852 $3.53 Million
Q1 2023

May 15, 2023
BUY
$3.75 - $6.65 $70,875 - $125,685
18,900 Added 2.64%
734,737 $2.98 Million
Q4 2022

Feb 10, 2023
BUY
$4.81 - $10.17 $311,644 - $658,924
64,791 Added 9.95%
715,837 $3.87 Million
Q3 2022

Nov 14, 2022
BUY
$4.44 - $10.48 $67,785 - $159,998
15,267 Added 2.4%
651,046 $6.53 Million
Q2 2022

Aug 12, 2022
SELL
$3.08 - $4.88 $1.84 Million - $2.92 Million
-598,992 Reduced 48.51%
635,779 $2.99 Million
Q1 2022

May 13, 2022
BUY
$3.91 - $6.73 $2.66 Million - $4.58 Million
679,798 Added 122.49%
1,234,771 $4.83 Million
Q4 2021

Feb 14, 2022
SELL
$6.54 - $15.31 $5.04 Million - $11.8 Million
-769,925 Reduced 58.11%
554,973 $3.75 Million
Q3 2021

Nov 12, 2021
BUY
$14.5 - $20.28 $19.2 Million - $26.9 Million
1,324,898 New
1,324,898 $19.7 Million

Others Institutions Holding ABOS

# of Institutions
78
Shares Held
41.8M
Call Options Held
57.7K
Put Options Held
749K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $74.9M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email